| Financial Year |
March 31 2023 |
| Monetary Funds |
122,637,750.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
192,011,507.50 |
| Advances to Suppliers |
4,996,163.27 |
| Other Receivables |
2,872,787.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,067,025.90 |
| Total Current Assets |
374,348,447.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
435,867,748.49 |
| Fixed Assetes |
2,164,810.49 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
251,844.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,284,789.47 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
445,375,446.33 |
| Total Assets |
819,723,894.17 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
80,691,305.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,612,606.07 |
| Taxes Payable |
7,197,717.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,004,903.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,595,851.14 |
| Other Current Liabilities |
146,741.35 |
| Sub-Total of Current Liabilities |
113,069,656.94 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
47,026.04 |
| Deferred Income Tax Liabilities |
94,271,328.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
94,498,729.64 |
| Total Liabilities |
207,568,386.58 |
| Paid-In Capital(Or Share Stock) |
262,520,973.00 |
| Capital Surplus |
743,696,505.11 |
| Surplus Reserve |
12,617,809.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-424,269,196.63 |
| Minority Stockholder's Interest |
17,589,416.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
594,566,091.38 |
| Owner's Equity（Stockholder's Equity） |
612,155,507.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
819,723,894.17 |
